A role for the membrane proteome in human chronic kidney disease erythrocytes

Translational Research

Volumn 160, Issue 5, 2012, Pages 374-383

  Alvarez Llamas, Gloria ^a   Zubiri, Irene ^a   Maroto, Aroa S ^a   De La Cuesta, Fernando ^a,b   Posada Ayala, María ^a   Martin Lorenzo, Marta ^a   Barderas, María G ^b   Fernandez Fernandez, Beatriz ^c   Ramos, Ana ^c   Ortiz, Alberto ^c   Vivanco, Fernando ^a,d  

^a 28400 Madrid   (Spain)

^b HOSPITAL NACIONAL DE PARAPLÉJICOS   (Spain)

^c Hospital UniversitarioFundación Jiménez Díaz   (Spain)

^d UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADDUCIN; CELL MEMBRANE PROTEIN; EZRIN; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 71; HEAT SHOCK PROTEIN 72; PROTEIN BETA ADDUCIN; PROTEOME; RADIXIN; RECOMBINANT ERYTHROPOIETIN; TROPOMODULIN; TROPOMODULIN 1; UNCLASSIFIED DRUG;

ADULT; AGED; ANEMIA; ARTICLE; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DISEASE ASSOCIATION; ERYTHROCYTE; FEMALE; HEMODIALYSIS PATIENT; HUMAN; HUMAN CELL; KIDNEY CELL; MALE; MASS SPECTROMETRY; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RENAL REPLACEMENT THERAPY; TWO DIMENSIONAL DIFFERENCE GEL ELECTROPHORESIS; UREMIA; WESTERN BLOTTING;

EID: 84867534050     PISSN: 19315244     EISSN: 18781810     Source Type: Journal    
DOI: 10.1016/j.trsl.2012.06.004     Document Type: Article

References (30)

1. F. Locatelli, P. Aljama, B. Canaud Anemia Working Group of European Renal Best Practice (ERBP) Target hemoglobin to aim for with erythropoiesis- stimulating agents: a position statement by ERBP following publication of the Trial to reduce cardiovascular events with Aranesp therapy (TREAT) study Nephrol Dial Transplant 25 2010 2846 2850
2. M.A. Pfeffer, E.A. Burdmann, C.Y. Chen TREAT Investigators A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease N Engl J Med 361 2009 2019 2032
3. A.K. Singh, L. Szczech, K.L. Tang CHOIR Investigators Correction of anemia with epoetin alfa in chronic kidney disease N Engl J Med 355 2006 2085 2098
4. S.D. Solomon, H. Uno, E.F. Lewis Trial to Reduce Cardiovascular Events with Aranesp Therapy (TREAT) Investigators Erythropoietic response and outcomes in kidney disease and type 2 diabetes N Engl J Med 363 2010 1146 1155
5. E.L. Penne, N.C. van der Weerd, M.P. Grooteman CONTRAST investigators Role of residual renal function in phosphate control and anemia management in chronic hemodialysis patients Clin J Am Soc Nephrol 6 2011 281 289
6. Y. Kikuchi, T. Koyama, and Y. Koyama Red blood cell deformability in renal failure Nephron 30 1982 8 14
7. D. Docci, C. del Vecchio, and P. Salvi Osmotic fragility of erythrocytes, cell deformability and secondary hyperparathyroidism in uremic patients on maintenance hemodialysis Clin Nephrol 23 1985 68 73
8. K.S. Brimble, A. McFarlane, N. Winegard, M. Crowther, and D.N. Churchill Effect of chronic kidney disease on red blood cell rheology Clin Hemorheol Microcirc 34 2006 411 420
9. F.F. Ibrahim, M.M. Ghannam, and F.M. Ali Effect of dialysis on erythrocyte membrane of chronically hemodialyzed patients Ren Fail 24 2002 779 790
10. A. Pantaleo, L. De Franceschi, E. Ferru, R. Vono, and F. Turrini Current knowledge about the functional roles of phosphorylative changes of membrane proteins in normal and diseased red cells J Proteomics 73 2010 445 455
11. V. Santoni, M. Molloy, and T. Rabilloud Membrane proteins and proteomics: un amour impossible? Electrophoresis 21 2000 1054 1070
12. G. Alvarez-Llamas, F. de la Cuesta, and M.G. Barderas A novel methodology for the analysis of membrane and cytosolic sub-proteomes of erythrocytes by 2-DE Electrophoresis 30 2009 4095 4108
13. A. Shevchenko, M. Wilm, O. Vorm, and M. Mann Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels Anal Chem 68 1996 850 858
14. F. de la Cuesta, G. Alvarez-Llamas, and A.S. Maroto A proteomic focus on the alterations occurring at the human atherosclerotic coronary intima Mol Cell Proteomics 10 4 2011 M110.003517
15. F.E. Vos, J.B. Schollum, and C.V. Coulter Red blood cell survival in long-term dialysis patients Am J Kidney Dis 58 2011 591 598
16. R. Joshi, D.M. Gilligan, and E. Otto Primary structure and domain organization of human alpha and beta adducin J Cell Biol 115 1991 665 675
17. W.A. Anong, T. Franco, and H. Chu Adducin forms a bridge between the erythrocyte membrane and its cytoskeleton and regulates membrane cohesion Blood 114 2009 1904 1912
18. D.M. Gilligan, L. Lozovatsky, and B. Gwynn Targeted disruption of the beta adducin gene (Add2) causes red blood cell spherocytosis in mice Proc Natl Acad Sci U S A 96 1999 10717 10722
19. T. Linde, G. Ronquist, and B. Sandhagen Treatment of renal anemia with recombinant human erythropoietin results in decreased red cell uptake of 45Ca Nephron 68 1994 419 426
20. D.M. Gilligan, and V. Bennett The junctional complex of the membrane skeleton Semin Hematol 30 1993 74 83
21. S. Tsukita, and S. Yonemura Cortical actin organization: lessons from ERM (ezrin/radixin/moesin) proteins J Biol Chem 274 1999 34507 34510
22. S. Louvet-Vallee ERM proteins: from cellular architecture to cell signaling Biol Cell 92 2000 305 316
23. E. Costa, S. Rocha, and P. Rocha-Pereira Altered erythrocyte membrane protein composition in chronic kidney disease stage 5 patients under hemodialysis and recombinant human erythropoietin therapy Blood Purif 26 2008 267 273
24. D. Lerche, R. Schmidt, and K. Zoellner Rheology in whole blood and in red blood cells under recombinant human erythropoietin therapy Contrib Nephrol 76 1989 299 303
25. A. Icardi, E. Paoletti, G.B. Traverso, C. Sarchi, G. Cappelli, and G. Molinelli Red cell membrane during erythropoietin therapy in hemodialysis and in hemodiafiltration Int J Artif Organs 14 1991 147 149
26. T. Linde, G. Ronquist, and B. Sandhagen Treatment of renal anaemia with recombinant human erythropoietin results in decreased red cell uptake of 45Ca Nephron 68 1994 419 426
27. T. Linde, B. Sandhagen, B.G. Danielson, and B. Wikström Impaired erythrocyte fluidity during treatment of renal anaemia with erythropoietin J Intern Med 231 1992 601 606
28. I.C. Macdougall, M.E. Davies, R.D. Hutton, G.A. Coles, and J.D. Williams Rheological studies during treatment of renal anaemia with recombinant human erythropoietin Br J Haematol 77 1991 550 558
29. I.C. Macdougall, M.E. Davies, and R.D. Hutton The treatment of renal anaemia in CAPD patients with recombinant human erythropoietin Nephrol Dial Transplant 5 1990 950 955
30. T. Linde, B. Sandhagen, and B. Wikström The required dose of erythropoietin during renal anemia treatment is related to the degree of impairment in erythrocyte deformability Nephrol Dial Transplant 12 1997 2375 2379